Ethics & Informed Consent: Randomised Controlled Trial (RCT) (Switzerland)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Randomised Controlled Trial (RCT) being conducted in Switzerland, study designs must align with the primary regulatory legislation: Swiss Federal Act on Research Involving Human Beings (Human Research Act, HRA). This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional Cantonal Ethics Committee. Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Randomised Controlled Trial (RCT), the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: High Risk (Interventional)

This interventional trial requires strict protocol adherence, allocation concealment, robust adverse event monitoring, and emergency unblinding guidelines.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: CONSORT statement.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under Federal Act on Data Protection (FADP).
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing Cantonal Ethics Committee so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Protecting trial subjects during this Randomised Controlled Trial (RCT) in Switzerland is rooted in the Belmont Report principles that guide modern medicine. Historically, severe lapses like the Tuskegee syphilis study ethics failures demonstrate why independent ethics boards must review trials in Switzerland. Drafting an exhaustive research study consent form ensures compliance with the informed consent Belmont Report guidelines. All clinical personnel are required to complete specialized human subjects research training on continuing review irb schedules. If animal models are used, investigators must detail compliance with the 3rs replacement reduction refinement of laboratory models. All records and signed consent sheets must reside on secure local servers in Switzerland to protect patient privacy and comply with national guidelines.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions